Cambridge Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $68.1K | Buy |
930
+55
| +6% | +$4.03K | ﹤0.01% | 392 |
|
|
2023
Q4 | $70.9K | Hold |
875
| – | – | ﹤0.01% | 381 |
|
|
2023
Q3 | $65.6K | Sell |
875
-60
| -6% | -$4.5K | ﹤0.01% | 389 |
|
|
2023
Q2 | $72.1K | Sell |
935
-206
| -18% | -$15.9K | ﹤0.01% | 389 |
|
|
2023
Q1 | $94.7K | Sell |
1,141
-173
| -13% | -$14.4K | ﹤0.01% | 361 |
|
|
2022
Q4 | $113K | Sell |
1,314
-60
| -4% | -$5.16K | 0.01% | 345 |
|
|
2022
Q3 | $85K | Sell |
1,374
-113
| -8% | -$6.99K | ﹤0.01% | 387 |
|
|
2022
Q2 | $92K | Sell |
1,487
-87
| -6% | -$5.38K | ﹤0.01% | 404 |
|
|
2022
Q1 | $94K | Sell |
1,574
-403
| -20% | -$24.1K | ﹤0.01% | 433 |
|
|
2021
Q4 | $144K | Buy |
+1,977
| New | +$144K | ﹤0.01% | 382 |
|
|
2016
Q3 | – | Sell |
-2,711
| Closed | -$226K | – | 259 |
|
|
2016
Q2 | $226K | Buy |
2,711
+260
| +11% | +$21.7K | 0.02% | 231 |
|
|
2016
Q1 | $225K | Sell |
2,451
-13
| -0.5% | -$1.19K | 0.02% | 210 |
|
|
2015
Q4 | $249K | Buy |
+2,464
| New | +$249K | 0.02% | 192 |
|